Insider · CIK 0001604471
Osamu R. Watanabe
officer
Files at MC (Moelis & Co). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2021 Incentive RSUsderivative | +23 | $0.00 | $0 | 2,166 | 20 d ago |
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2022 Incentive RSUsderivative | +45 | $0.00 | $0 | 4,130 | 20 d ago |
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2023 Incentive RSUsderivative | +53 | $0.00 | $0 | 4,906 | 20 d ago |
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2024 Incentive RSUsderivative | +59 | $0.00 | $0 | 5,430 | 20 d ago |
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2025 Incentive RSUsderivative | +67 | $0.00 | $0 | 6,166 | 20 d ago |
| Sep 17, 2026 | MC Moelis & Co | AGrant or award 2025 Special Incentive RSUsderivative | +15 | $0.00 | $0 | 1,433 | 20 d ago |
| Dec 2, 2024 | MC Moelis & Co | AGrant or award 2019 Incentive RSUsderivative | +35 | $0.00 | $0 | 4,413 | Dec 4, 2024 |
| Dec 2, 2024 | MC Moelis & Co | AGrant or award 2020 Incentive RSUsderivative | +34 | $0.00 | $0 | 4,272 | Dec 4, 2024 |
| Dec 2, 2024 | MC Moelis & Co | AGrant or award 2021 Incentive RSUsderivative | +47 | $0.00 | $0 | 6,044 | Dec 4, 2024 |
| Dec 2, 2024 | MC Moelis & Co | AGrant or award 2022 Incentive RSUsderivative | +60 | $0.00 | $0 | 7,682 | Dec 4, 2024 |
| Dec 2, 2024 | MC Moelis & Co | AGrant or award 2023 Incentive RSUsderivative | +60 | $0.00 | $0 | 7,603 | Dec 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.